Skip to main content

ATLASense Biomed Ltd. for Safe Hospital-Care at Home.

ATLASense Biomed makes REPHAEL, a chest-worn sensor and cloud service that sends a patient's vital signs to clinical teams every second, in the ward and at home. The reusable unit measures 19 signal channels, including ECG and breathing-muscle activity, and the company supplies it as a managed service rather than selling devices. Algorithms flag respiratory deterioration, arrhythmias, falls and suspected sepsis.

Traction 6/10
Hod HaSharon, Israel · HQ
Founded 202011700+ followers
  • Internet of Things
  • Medical Devices
  • Software Only
  • Artificial Intelligence
  • Digital Health
  • Hardware
  • Healthcare Technology
Updated today

Funding

Raised to date

$2.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Tal Or

Co-founder / CEO

Product

Problem

Hospitals and home-care teams check patients at set times, so a condition that worsens between checks can go unnoticed until the next observation or an emergency transfer. Care teams taking on more hospital-at-home patients need to see how each patient is changing between visits.

Solution

ATLASense Biomed's REPHAEL is a monitoring system built around a reusable chest unit that a patient wears. The unit records 19 physiological signal channels every second, covering electrical and mechanical heart activity, breathing from three sources including the breathing muscles, skin conductance, temperature, position and movement. The signals go to the cloud, where algorithms combine physiological models and machine learning to produce more than 60 parameters and to predict respiratory deterioration, detect arrhythmias and falls, and screen for suspected sepsis. Clinicians follow the patient's condition on a shared view across the ward, step-down care, hospital-at-home and community care, so the same team can see changes across settings. The company supplies the units as a managed fleet: a charged, prepared unit is exchanged for the one in use, and the service covers electrodes, cleaning and staff time.

Target Audience

Hospitals, health systems and home-care providers running hospital-at-home and step-down programs.

Features

  • Follow a patient's vital-sign trends continuously rather than at scheduled checks.
  • Get alerts for predicted respiratory deterioration, arrhythmias, falls and suspected sepsis.
  • Measure blood pressure continuously without a cuff.
  • Detect intention to rise, such as a patient trying to stand unassisted.
  • Track movement, body position and fall risk.
  • Use one clinical view from the ward through step-down care to the patient's home.
This profile is AI-generated and may contain inaccuracies.